Atea Pharmaceuticals Inc Stock, NASDAQ:AVIR
125 Summer Street, Boston, Massachusetts 02110
United States of America
Number of Employees: 39
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.